Siemens Healthineers debuted the Magnetom RT Pro edition of Magnetom Vida, a version of the company’s 3T magnetic resonance imaging (MRI) scanner designed for radiation therapy (RT) planning, at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego. The scanner features the new BioMatrix Technology, which overcomes unwanted variability by addressing the inherent anatomical and physiological differences of patients. It includes a comprehensive package of hardware and software that supports optimal treatment planning.

Virtual Imaging, a wholly owned subsidiary of Canon U.S.A. Inc., announced that Sovah Health – Martinsville (formerly Memorial Hospital of Martinsville & Henry County) in Martinsville, Va., has outfitted its radiology department with the RadPro Mobile 40kW Flex Plus digital X-ray system. Seeking to upgrade its older devices and rectify excessive downtime issues, Sovah Health - Martinsville, with the assistance of Radon Medical Imaging, an authorized Virtual Imaging dealer, chose the RadPro Mobile 40kW Flex Plus System. According to the customer, the decision to acquire this specific system was due to the device’s reputation for consistent uptime, high-quality imaging and mobility.

A new study involving patients with stage IV cancer finds treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the cancer. In the phase II trial, patients with end-stage cancer that had spread to the lungs or liver demonstrated a favorable response to the combined treatment. Between 30 and 60 percent of the patients, depending on the treatment arm, found that their cancer stopped spreading. Findings were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease. Patients in the study with detectable levels of circulating tumor DNA (ctDNA) shortly after treatment all had recurrences within two years, while all but one of the patients without detectable ctDNA shortly after treatment remained disease-free and survived long-term. Conventional imaging, conversely, was not prognostic for recurrence or survival. Findings were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

Network Radiology, a leading independent radiology center and teleradiology service provider in Cleveland, is using Exa PACS/RIS from Konica Minolta Healthcare Americas Inc. to help increase productivity and enable high reading volumes for both business applications. With a growing number of imaging studies between the two business segments, Network Radiology relies on Exa PACS server-side rendering and the solution’s diagnostic-quality zero footprint universal viewer for fast access to imaging studies from virtually any location, workstation or modality.

CorTechs Labs announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its NeuroQuant software for quantitative brain volume analysis. Previously cleared for automatic labeling and volumetric quantification of segmentable brain structures from magnetic resonance images (MRIs), this latest clearance unveils updated and advanced NeuroQuant features for the U.S. market.

University of Iowa Health Care recently purchased Carestream’s Vue Motion enterprise viewer, lesion management and mammography/tomography software to augment the capabilities of its existing Carestream Clinical Collaboration Platform.

A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care — undiagnosed depression. Among the 40 percent of patients at the center who were diagnosed with depression, three in four had not previously been told they were depressed. Female patients and disabled patients also were more likely to be depressed, according to research presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

Radiation therapy following mastectomy for intermediate-stage, high-risk breast cancer can be shortened from five to three weeks while maintaining tumor control rates in the breast and surrounding region that are equivalent to conventional treatment, according to new research. The findings were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

September 28, 2017 — Barco will use NeoLogica’s RemotEye Suite universal viewing solution software to enrich and simplify radiology and breast imaging display demonstrations in the United States and Canada. The software allows all types of patient images – including 3-D mammography – to be displayed in one easy-to-use application.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now